Aliases & Classifications for Laryngeal Disease

Summaries for Laryngeal Disease

MalaCards based summary : Laryngeal Disease, also known as laryngeal diseases, is related to laryngitis and fungal esophagitis, and has symptoms including dyspnea and stridor. An important gene associated with Laryngeal Disease is ATP12A (ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit). The drugs Lansoprazole and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include lung, brain and lymph node.

Related Diseases for Laryngeal Disease

Diseases related to Laryngeal Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 61)
# Related Disease Score Top Affiliating Genes
1 laryngitis 32.5 ATP12A ATP4A
2 fungal esophagitis 10.6 ATP12A ATP4A
3 bladder calculus 10.6 ATP12A ATP4A
4 gastrointestinal neuroendocrine benign tumor 10.6 ATP12A ATP4A
5 neonatal candidiasis 10.6 ATP12A ATP4A
6 photoallergic dermatitis 10.6 ATP12A ATP4A
7 squamous papillomatosis 10.6 ATP12A ATP4A
8 acute laryngitis 10.6 ATP12A ATP4A
9 gastroduodenal crohn's disease 10.5 ATP12A ATP4A
10 gastric neuroendocrine neoplasm 10.5 ATP12A ATP4A
11 toxic megacolon 10.5 ATP12A ATP4A
12 aspiration pneumonitis 10.5 ATP12A ATP4A
13 postsurgical hypothyroidism 10.5 ATP12A ATP4A
14 gastric antral vascular ectasia 10.5 ATP12A ATP4A
15 esophageal candidiasis 10.5 ATP12A ATP4A
16 duodenitis 10.5 ATP12A ATP4A
17 rumination disorder 10.5 ATP12A ATP4A
18 bile reflux 10.5 ATP12A ATP4A
19 granulomatous gastritis 10.5 ATP12A ATP4A
20 active peptic ulcer disease 10.5 ATP12A ATP4A
21 ischemic neuropathy 10.5 ATP12A ATP4A
22 capillary disease 10.5 ATP12A ATP4A
23 peptic esophagitis 10.5 ATP12A ATP4A
24 duodenal disease 10.5 ATP12A ATP4A
25 dyskinesia of esophagus 10.5 ATP12A ATP4A
26 hernia, hiatus 10.5 ATP12A ATP4A
27 congenital disorder of deglycosylation 10.5 ATP12A ATP4A
28 anismus 10.5 ATP12A ATP4A
29 esophageal atresia/tracheoesophageal fistula 10.5 ATP12A ATP4A
30 lymphocytic colitis 10.5 ATP12A ATP4A
31 clostridium difficile colitis 10.5 ATP12A ATP4A
32 lower urinary tract calculus 10.5 ATP12A ATP4A
33 aspiration pneumonia 10.5 ATP12A ATP4A
34 diarrhea 1, secretory chloride, congenital 10.4 ATP12A ATP4A
35 chronic laryngitis 10.4 ATP12A ATP4A
36 chronic intestinal vascular insufficiency 10.4 ATP12A ATP4A
37 eosinophilic gastritis 10.4 ATP12A ATP4A
38 polyposis, skin pigmentation, alopecia, and fingernail changes 10.4 ATP12A ATP4A
39 esophageal varix 10.4 ATP12A ATP4A
40 esophagus adenocarcinoma 10.4 ATP12A ATP4A
41 myopathy, x-linked, with excessive autophagy 10.4 ATP12A ATP4A
42 gastric lymphoma 10.4 ATP12A ATP4A
43 pancreatic steatorrhea 10.4 ATP12A ATP4A
44 pneumatosis cystoides intestinalis 10.4 ATP12A ATP4A
45 superior mesenteric artery syndrome 10.3 ATP12A ATP4A
46 jejunoileitis 10.3 ATP12A ATP4A
47 functional gastric disease 10.3 ATP12A ATP4A
48 lateral medullary syndrome 10.3 ATP12A ATP4A
49 paine syndrome 10.3 ATP12A ATP4A
50 esophagitis, eosinophilic, 1 10.2 ATP12A ATP4A

Graphical network of the top 20 diseases related to Laryngeal Disease:



Diseases related to Laryngeal Disease

Symptoms & Phenotypes for Laryngeal Disease

UMLS symptoms related to Laryngeal Disease:


dyspnea, stridor

Drugs & Therapeutics for Laryngeal Disease

Drugs for Laryngeal Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 452)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 103577-45-3 3883
2
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 137-58-6 3676
3
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 15663-27-1 84093 441203 2767
4
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
5
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 73590-58-6 4594
6
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
7
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 2078-54-8 4943
8
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
9
Acetylcysteine Approved, Investigational Phase 4,Not Applicable 616-91-1 12035
10
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 138530-94-6, 103577-45-3 9578005
11
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2 90566-53-3 62924
12
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
13
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
14
Esomeprazole Approved, Investigational Phase 4,Phase 3,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
15
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 5281106 54677470
16
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
17
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
18
Cidofovir Approved Phase 4 113852-37-2 60613
19
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
20
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-02-2 5743
21
Montelukast Approved Phase 4 158966-92-8 5281040
22
Histamine Approved, Investigational Phase 4,Phase 3,Not Applicable 75614-87-8, 51-45-6 774
23
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
24
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
25
Salmeterol xinafoate Phase 4 94749-08-3 56801
26 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
28
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
31 Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Phase 4
32 Adrenergic Agents Phase 4,Phase 3,Phase 2,Not Applicable
33 Adrenergic Agonists Phase 4,Phase 3,Phase 2,Not Applicable
34 Adrenergic alpha-Agonists Phase 4,Phase 3,Phase 2,Not Applicable
35 Adrenergic beta-2 Receptor Agonists Phase 4
36 Adrenergic beta-Agonists Phase 4,Phase 3,Phase 2,Not Applicable
37 Mydriatics Phase 4,Phase 3,Phase 2,Not Applicable
38 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Sodium Channel Blockers Phase 4,Phase 3,Not Applicable
40 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Cyclooxygenase Inhibitors Phase 4,Phase 1,Phase 2,Not Applicable
42 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
43 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
45 N-monoacetylcystine Phase 4,Not Applicable
46 Hormone Antagonists Phase 4,Phase 2,Phase 3,Not Applicable
47 Anesthetics, General Phase 4,Phase 2,Phase 3,Not Applicable
48 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
49 Anesthetics, Inhalation Phase 4,Phase 2,Phase 3,Not Applicable
50 Anesthetics, Intravenous Phase 4,Phase 2,Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 811)
# Name Status NCT ID Phase Drugs
1 THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS Unknown status NCT02241876 Phase 4 N-acetylcysteine
2 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
3 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
4 Interpretation of Transnasal Esophagoscopy Findings Completed NCT00372918 Phase 4
5 Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? Completed NCT00444145 Phase 4 Prevacid
6 Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Completed NCT00373997 Phase 4
7 Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI Completed NCT00611195 Phase 4 propofol, remifentanil
8 Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients Completed NCT02622880 Phase 4
9 Preoperative Use of Montelukast Sodium Completed NCT02494466 Phase 4 montelukast sodium
10 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
11 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
12 Pregabalin in the Treatment of Essential Tremor Completed NCT00646451 Phase 4 pregabalin;placebo capsules
13 Videolaryngoscope vs Classic Laryngoscope in Teaching Neonatal Endotracheal Intubation: a Randomized Controlled Trial. Completed NCT01394783 Phase 4
14 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
15 Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients Completed NCT02926573 Phase 4 Gabapentin;Placebo
16 Intubation of Patients With an Unstable Cervical Spine Using the CMAC Device Completed NCT01113723 Phase 4
17 Effectiveness and Safety of the Levitan Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway Completed NCT01491984 Phase 4
18 Comparative Effectiveness of Intubating Devices in the Morbidly Obese Completed NCT01114945 Phase 4
19 Community Care for Croup (RCT) Completed NCT01042145 Phase 4 Prednisone;Dexamethasone
20 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
21 Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis Completed NCT03086070 Phase 4 Omeprazole 20mg;Placebo oral capsule
22 Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness. Completed NCT01990781 Phase 4 LD: Lidocaine and dexamethasone;L:Lidocaine;D: Dexamethasone;N: Normal saline (placebo)
23 Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying Completed NCT01956682 Phase 4
24 Quality of Life Validation in Laryngitis Completed NCT00641264 Phase 4 Omeprazole
25 Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux Completed NCT00628667 Phase 4 Esomeprazole;Placebo
26 Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal Recruiting NCT03461328 Phase 4 Magnesium Sulphate
27 A Randomized Controlled Cross Over Study Comparing Sugammadex and Placebo Recruiting NCT03087513 Phase 4 Sugammadex Injection;Placebos
28 The Effect and Safety of Low Dose Nebulized Epinephrine in Croup Recruiting NCT01664507 Phase 4 conventional dose epinephrine;low dose epinephrine
29 Comparison of Double Lumen Tube Placement Techniques Recruiting NCT02495259 Phase 4
30 Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients Terminated NCT00665418 Phase 4 sevoflurane
31 Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness Terminated NCT00637416 Phase 4 Lansoprazole
32 Anti-reflux Control to Decrease Post Tonsillectomy Pain Terminated NCT01777854 Phase 4 Omeprazole
33 Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux Terminated NCT00369265 Phase 4 Lansoprazole
34 Comparison of Voice Therapy and Antireflex Therapy in LPR Withdrawn NCT02530879 Phase 4 Omeprazole, Lansoprazole, Esomeprazole, Rantidine
35 The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux Withdrawn NCT02123498 Phase 4 Omeprazole;Ranitidine;Pantoprazole
36 A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux Withdrawn NCT01308502 Phase 4
37 Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment Unknown status NCT00935675 Phase 3 Escitalopram
38 Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer. Unknown status NCT01124409 Phase 3
39 PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer Unknown status NCT00720070 Phase 3
40 S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer Unknown status NCT00336947 Phase 3 tegafur-gimeracil-oteracil potassium;tegafur-uracil
41 Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer Unknown status NCT00002659 Phase 3 cisplatin-e therapeutic implant
42 Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease Unknown status NCT02533349 Phase 3 Motilitone;Pantoprazole;Placebo
43 Isoflurane Versus Propofol for Removal of LMA in Children Unknown status NCT01958138 Phase 2, Phase 3 comparison of group-P (low dose propofol with isoflurane) versus group-D (alone isoflurane)
44 Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube Unknown status NCT01288248 Phase 3
45 the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy Unknown status NCT00497588 Phase 3
46 Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma Completed NCT00169182 Phase 3 DOCETAXEL
47 Randomized Trial of ARCON in Larynx Cancer Completed NCT00147732 Phase 3
48 Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx Completed NCT00002496 Phase 3 chemotherapy;cisplatin;fluorouracil
49 Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx Completed NCT00002839 Phase 3 cisplatin;fluorouracil
50 Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx Completed NCT00004234 Phase 3

Search NIH Clinical Center for Laryngeal Disease

Cochrane evidence based reviews: laryngeal diseases

Genetic Tests for Laryngeal Disease

Anatomical Context for Laryngeal Disease

MalaCards organs/tissues related to Laryngeal Disease:

41
Lung, Brain, Lymph Node, Testes, Thyroid, Liver, Tongue

Publications for Laryngeal Disease

Articles related to Laryngeal Disease:

(show all 43)
# Title Authors Year
1
A Case Series of the Probability Density and Cumulative Distribution of Laryngeal Disease in a Tertiary Care Voice Center. ( 28949246 )
2017
2
The laryngeal disease of the German Emperor Friedrich III: treatment failure or fateful course. ( 26894417 )
2016
3
Health-related Quality of Life as Studied by EORTC QLQ and Voice Handicap Index Among Various Patients With Laryngeal Disease. ( 27520510 )
2016
4
A Population-Based Cross-Sectional Study of Alcohol Consumption and Risk of Benign Laryngeal Disease in Korean Adults. ( 26810937 )
2016
5
Laryngeal disease in dogs and cats. ( 24268331 )
2014
6
Prevalence of laryngeal disease in South Korea: data from the Korea National Health and Nutrition Examination Survey from 2008 to 2011. ( 24532524 )
2014
7
Multidetector computed tomography in nonmalignant laryngeal disease. ( 23086262 )
2012
8
Laryngeal disease in cats: a retrospective study of 35 cases. ( 19539507 )
2009
9
Automated speech analysis applied to laryngeal disease categorization. ( 18346812 )
2008
10
Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. ( 17417109 )
2007
11
The prevalence of laryngeal disease in a large population of competition draft horses. ( 16911159 )
2006
12
Predicting difficult orotracheal intubation in pharyngo-laryngeal disease: preliminary results of a composite index. ( 12514157 )
2003
13
[Content of protein lactoferrin in precancer laryngeal disease]. ( 14605655 )
2003
14
Obstructive inflammatory laryngeal disease in three cats. ( 11919016 )
1999
15
Acetowhite staining in the detection of laryngeal disease. ( 8818497 )
1996
16
Diagnosis and management of laryngeal disease in the dog and cat. ( 7817489 )
1994
17
Gastroesophageal reflux and laryngeal disease. ( 8368919 )
1993
18
Allergy and laryngeal disease. ( 1549386 )
1992
19
PC based system for analysis of the voice of patients with laryngeal disease. ( 1782887 )
1991
20
Microsurgery in otolaryngology: benign laryngeal disease. ( 2687615 )
1989
21
Phonatory airflow analysis in patients with laryngeal disease. ( 3674651 )
1987
22
Laser surgery for benign laryngeal disease. Conservation and ergonomics. ( 6495137 )
1984
23
Use of the carbon dioxide laser in the endoscopic management of organic laryngeal disease. ( 6422398 )
1983
24
Laser surgery in benign laryngeal disease. ( 7180425 )
1982
25
Evaluation of computerized tomography, cinelaryngoscopy, and laryngography in determining the extent of laryngeal disease. ( 475240 )
1979
26
Observations on laryngeal disease, laryngeal behavior and voice. ( 791049 )
1976
27
Early diagnostic signs and symptoms of laryngeal disease. ( 1121224 )
1975
28
Laboratory diagnosis of laryngeal disease. ( 1186398 )
1975
29
Letter: Early detection of laryngeal disease. ( 1153363 )
1975
30
Spontaneous laryngeal disease in the canine. ( 1202306 )
1975
31
Detection of laryngeal disease by computer technique. ( 4902587 )
1970
32
Voice prints in laryngeal disease. ( 5438733 )
1970
33
Clinical evaluation of vocal velocity index in laryngeal disease. ( 5437644 )
1970
34
Vocal rest in laryngeal disease. ( 13571871 )
1958
35
Present concepts of laryngeal disease. ( 18903339 )
1948
36
The RA'le of the Lymphatics in Laryngeal Disease; and the RA'le of the Larynx in Lymphatic Disease. ( 19985030 )
1926
37
Laryngeal Disease of Obscure Nature. ( 19978744 )
1915
38
Case of Laryngeal Disease presenting Atypical Features. ( 19976876 )
1913
39
Laryngeal Disease in a Man, aged 45, probably Tuberculous, but presenting appearances of Epithelioma. ( 19975097 )
1911
40
Laryngeal Disease. ( 19972942 )
1908
41
Laryngeal Disease (? syphilitic). ( 19972933 )
1908
42
A Discussion on the Treatment of Laryngeal Disease in Tuberculosis. ( 20753126 )
1890
43
Remarks on Four Cases of Laryngeal Disease. ( 20750040 )
1881

Variations for Laryngeal Disease

Expression for Laryngeal Disease

Search GEO for disease gene expression data for Laryngeal Disease.

Pathways for Laryngeal Disease

GO Terms for Laryngeal Disease

Biological processes related to Laryngeal Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 potassium ion import GO:0010107 9.37 ATP12A ATP4A
2 ATP hydrolysis coupled proton transport GO:0015991 9.32 ATP12A ATP4A
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP12A ATP4A
4 cellular potassium ion homeostasis GO:0030007 9.16 ATP12A ATP4A
5 sodium ion export across plasma membrane GO:0036376 8.96 ATP12A ATP4A
6 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP12A ATP4A

Molecular functions related to Laryngeal Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A

Sources for Laryngeal Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....